On June 11, Shougang LanzaTech (02553.HK) rose 6.73% in regular trading, trading at HKD 35.8/share, with trading volume of HKD 23.59 million. The stock has now surged over 145% from its IPO price of HKD 14.6.

The continued upward momentum is driven by the company's June 8 announcement that its global first industrial tail gas biological synthesis anhydrous ethanol project successfully completed seed tank dry powder inoculation, officially entering trial production. This marks the world's first industrial-scale application demonstration of this technology pathway. The project utilizes the company's proprietary second-generation negative-carbon technology, capable of directly consuming 0.5 tonnes of CO₂ per tonne of ethanol produced, achieving a carbon fixation rate of 93.5%, certified at internationally leading levels.

Shougang LanzaTech listed on the Hong Kong Stock Exchange on June 3 with 1,421x oversubscription in its public offering. According to Frost & Sullivan, the company holds 58.4% global market share by revenue in the CCUS sector utilizing synthetic biology technology, making it the undisputed segment leader with four operational production facilities across China totaling 210,000 tonnes of annual ethanol capacity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)